COMMUNIQUÉS West-GlobeNewswire

Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
10/04/2026
SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]
Checkerspot Introduces Algolein™, a New Line of Specialized Lipids from Microalgae for Personal Care and Cosmetics
10/04/2026
Algolein™ debuts with a high-oleic algal oil under the name Algolein™ TG C18/80 designed without genetic modification using microalgae fermentation to deliver targeted performance, consistency, and sustainability [...]
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
10/04/2026
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed’s CFO, Jack Glenn, will [...]
Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System
10/04/2026
Bay Alarm Medical Recognized for Excellence in Safety and Innovation by Medical Daily Concord, CALIFORNIA, April 10, 2026 (GLOBE NEWSWIRE) -- Bay Alarm Medical, a leader in personal emergency response systems, has been [...]
Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering
10/04/2026
OCEANSIDE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the [...]
Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed
10/04/2026
Collaboration marks the first clinical pilot of AI-assisted MRI analysis for endometriosis. Paris, France, April 10, 2026 (GLOBE NEWSWIRE) -- Matricis.ai, a healthcare technology company developing artificial [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026
10/04/2026
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2026
10/04/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
10/04/2026
First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2026 Revenue [...]
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
10/04/2026
First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2026 Revenue [...]
EUROBIO SCIENTIFIC : RESULTAT ANNUEL 2025
10/04/2026
RESULTAT ANNUEL 2025 Progression du chiffre d’affaires annuel de 9% à 168 M€ Déploiement de la stratégie du Groupe : Ventes des produits propriétaires en hausse de 20%, à 35% du Chiffre d’affaires Internationalisation [...]
EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS
10/04/2026
2025 ANNUAL RESULTS Annual revenue up 9% to €168 million Roll-out of the Group’s strategy: Sales of proprietary products up 20%, accounting for 35% of revenue Internationalisation: 42% of revenue generated outside [...]
Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift
10/04/2026
Landmark philanthropic investment from the Hennick Family Foundation will accelerate innovation and patient care at North America’s first fully digital hospital TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- Humber River [...]
Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®
10/04/2026
DENVER, April 10, 2026 (GLOBE NEWSWIRE) -- Unyte Health, a leader in listening therapy interventions, is proud to announce that Vital Links and Vital Sounds have officially joined its growing family of clinical [...]
NeurAxis, Inc. Announces Preferred Stock Dividend
10/04/2026
CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating [...]
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
10/04/2026
Oral presentations feature phentolamine ophthalmic solution 0.75% RESEARCH TRIANGLE PARK, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage [...]
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
10/04/2026
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing Symposium MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc [...]
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
10/04/2026
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
10/04/2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- [...]

Pages